SPISANI, Susanna
 Distribuzione geografica
Continente #
NA - Nord America 10.869
AS - Asia 5.551
EU - Europa 2.737
SA - Sud America 897
AF - Africa 132
Continente sconosciuto - Info sul continente non disponibili 115
OC - Oceania 5
Totale 20.306
Nazione #
US - Stati Uniti d'America 10.625
SG - Singapore 2.101
CN - Cina 1.447
BR - Brasile 694
VN - Vietnam 635
UA - Ucraina 602
DE - Germania 591
HK - Hong Kong 461
TR - Turchia 342
GB - Regno Unito 330
IT - Italia 294
FI - Finlandia 242
FR - Francia 188
SE - Svezia 157
RU - Federazione Russa 129
MX - Messico 111
JP - Giappone 107
IN - India 106
BD - Bangladesh 98
CA - Canada 98
AR - Argentina 66
ZA - Sudafrica 57
PL - Polonia 53
IQ - Iraq 41
ID - Indonesia 38
ES - Italia 34
CO - Colombia 32
PK - Pakistan 29
BE - Belgio 27
NL - Olanda 27
EC - Ecuador 23
CL - Cile 22
VE - Venezuela 20
PE - Perù 18
PH - Filippine 18
SA - Arabia Saudita 18
LT - Lituania 17
UZ - Uzbekistan 14
MY - Malesia 13
MA - Marocco 12
TN - Tunisia 12
PY - Paraguay 11
AE - Emirati Arabi Uniti 10
ET - Etiopia 10
IR - Iran 10
KE - Kenya 10
JM - Giamaica 9
CZ - Repubblica Ceca 8
IL - Israele 8
OM - Oman 7
BO - Bolivia 6
CH - Svizzera 6
DZ - Algeria 6
JO - Giordania 6
CR - Costa Rica 5
EG - Egitto 5
NP - Nepal 5
TH - Thailandia 5
AT - Austria 4
EU - Europa 4
HN - Honduras 4
PT - Portogallo 4
SN - Senegal 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
XK - ???statistics.table.value.countryCode.XK??? 4
AU - Australia 3
AZ - Azerbaigian 3
GE - Georgia 3
KG - Kirghizistan 3
KZ - Kazakistan 3
LB - Libano 3
RO - Romania 3
SV - El Salvador 3
AO - Angola 2
BG - Bulgaria 2
BS - Bahamas 2
BW - Botswana 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
GR - Grecia 2
GT - Guatemala 2
KR - Corea 2
LK - Sri Lanka 2
LY - Libia 2
MD - Moldavia 2
MK - Macedonia 2
MU - Mauritius 2
NG - Nigeria 2
PS - Palestinian Territory 2
RS - Serbia 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BH - Bahrain 1
BJ - Benin 1
BT - Bhutan 1
Totale 20.177
Città #
Singapore 1.327
Ashburn 1.158
Woodbridge 962
Fairfield 942
Houston 670
Jacksonville 624
San Jose 582
Chandler 536
Santa Clara 502
Ann Arbor 485
Beijing 479
Hong Kong 452
Seattle 363
Wilmington 354
Dallas 319
Cambridge 285
Izmir 196
Ho Chi Minh City 190
Munich 190
Nanjing 184
New York 182
Los Angeles 180
Hanoi 158
Princeton 125
Tokyo 102
Lauterbourg 101
San Diego 94
Helsinki 93
Boardman 88
Milan 87
São Paulo 82
Buffalo 79
Mexico City 79
Shanghai 73
Bremen 61
Ferrara 58
Nanchang 53
Orem 53
Hefei 52
Council Bluffs 51
Montreal 48
Shenyang 48
London 46
Warsaw 46
Tianjin 43
Hebei 41
Addison 37
Changsha 37
Chicago 33
Dong Ket 33
Johannesburg 33
Chennai 32
Denver 31
Atlanta 30
San Mateo 30
Brooklyn 28
Jinan 28
Toronto 28
Turku 28
Da Nang 27
The Dalles 27
Stockholm 26
Auburn Hills 22
Haiphong 22
Mountain View 22
Poplar 22
Brussels 21
Philadelphia 21
Phoenix 21
Jiaxing 20
Frankfurt am Main 19
Biên Hòa 18
Hải Dương 18
Rio de Janeiro 18
Manchester 17
Moscow 17
Verona 17
Boston 16
Amsterdam 15
Baghdad 15
Kunming 15
San Francisco 15
Ankara 14
Zhengzhou 14
Augusta 13
Dearborn 13
Dhaka 13
Falkenstein 13
Medellín 13
Tappahannock 13
Bắc Ninh 12
Charlotte 12
Norwalk 12
Redwood City 12
Brasília 11
Curitiba 11
Rome 11
Tashkent 11
Columbus 10
Goiânia 10
Totale 14.000
Nome #
Anti-inflammatory and analgesic effects displayed by peptides derived from PKI55 protein, an endogenous protein kinase C inhibitor 406
C- and N-terminal residue effect on peptide derivatives' antagonism toward the formyl-peptide receptor 396
1-Methyl and 1-(2-hydroxyalkyl)-5-(3-alkyl/cycloalkyl/phenyl/naphthylureido)-1H-pyrazole-4-carboxylic acid ethyl esters as potent human neutrophil chemotaxis inhibitors 373
A cyclic peptide T analogue with high chemotactic activity 288
Differential Effects of Angelicin Analogues on NF-kB Activity and IL-8 Gene Expression in Cystic Fibrosis IB3-1 Cells 275
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 244
6-(hydroxyphenyl)imidazo[2,1-b]thiazoles as potential antiinflammatory agents: Effects on human neutrophil functions 235
FIBROBLASTS INCREASE ADHESION TO NEUTROPHILS AFTER STIMULATION WITH PHORBOL ESTER AND CYTOKINES 229
Biological activity of for-Met-Leu-Phe-OMe analogs: relevant substitutions specifically trigger killing mechanisms in human neutrophils 227
Modulation of neutrophil functions by activated platelet release factors 222
A CD4/T4 receptor peptide ligand labeled with technetium-99m: Synthesis and biological activity 222
A hydrophilic residue at position 2 can improve specific biological responses in fMLP-OMe analogs. 220
N-Aryl-2-phenyl-2,3-dihydro-imidazo[1,2-b]pyrazole-1-carboxamides 7-substituted strongly inhibiting both fMLP-OMe- and IL-8-induced human neutrophil chemotaxis 219
Deficiency of neutrophil membrane antigen detected by monoclonal antibody in rheumatoid arthritis 214
Evaluation of CR1 expression in neutrophils from chronic myeloid leukaemia: relationship between prognosis and cellular activity 214
Modified chemotactic peptides: synthesis, crystal conformation, and activity of For‐Hse(Me)‐Leu‐Phe‐OMe 212
For-Met-Lys-Phe-For-Met-Lys-Phe-: a new cyclic analogue of the chemotactic formylpeptides. 211
Ring-opened analogs of indomethacin affecting human neutrophil functions 211
An evaluation of fMLP pocket dimensions and features using formyltetrapeptides 207
Studies on fMLP-receptor interaction and signal transduction pathway by means of fMLP-OMe selective analogues 205
Modulation of neutrophil phospholipase C activity and cyclic AMP levels by fMLP-OMe analogues 204
Attivita' tumoricida dei neutrofili 204
Dual mechanism in induction of human neutrophil cytotoxicity: Activation of protein kinase C and elevation in intracellular calcium 202
Met-Ile-Phe-Leu derivatives: full and partial agonists of human neutrophil formylpeptide receptors 201
Properties of a novel chemotactic esapeptide, an analogue of the prototypical N-formylmethionyl peptide 199
Conformational Aspects of Human Formyl-peptide Receptor Agonists 196
Study of synthetic peptides derived from the PKI55 protein, a protein kinase C modulator, in human neutrophils stimulated by the methyl ester derivative of the hydrophobic N-formyl tripeptide for-Met-Leu-Phe-OH 194
b-peptido sulfonamides. For-Met-Leu-Phe-OMe analogues containing taurine and chiral b-amino-ethansulfonic acid residues 194
Phe-D-Leu-Phe-D-Leu-Phe derivatives as formylpeptide receptor antagonists in human neutrophils: cellular and conformational aspects 193
Modified chemotactic peptides: Synthesis, conformation, and activity of HCO-Thp-Ac6c-Phe-OMe 191
Conformational aspects of human formylpeptide receptor antagonists 188
Hydrophilic residues at position 3 highlight unforeseen features of the fMLP receptor pocket 188
Bioactive fMLF-OMe analogs containing a N-terminal oximic or formylhydrazonic moiety 186
Activation of signal tranduction pathway leading to chemotaxis in human neutrophils by a pure chemoattractant. 186
Nociceptin/orphanin FQ stimulates human monocyte chemotaxis via NOP receptor activation 186
DEPRESSED NEUTROPHIL-MEDIATED TUMOR CELL CYTOTOXICITY IN SUBJECTS AFFECTED BY HEREDITARY MYELOPEROXIDASE DEFICIENCY AND SECONDARY NEOPLASIA 185
Inhibition of neutrophil responses by cyclosporin A. An insight into molecular mechanisms 184
Differences arising in human neutrophil activation passing from N-formyl to N-acetyl-oligopeptides 182
2,3-dihydro-1Himidazo[1,2-b]pyrazole derivatives as potential neutrophils funtions inhibitor 182
Biological variation responses in fMLP-OMe analogs, introducing bulky protecting groups on the side-chain of hydrophilic residues at position 2 181
An exhaustive insight into the pocket charge features of the methionine receptor using fMLP analogs. 179
An exhaustive insight into the pocket cherge features of the methionine receptor using fMLP analogs. 178
New chemotactic dimeric peptides show high affinity and potency at the human formylpeptide receptor 178
Differential involvement of kinase pathways is required for human neutrophil function triggered by formylpeptides 176
HLA B51 antigen associated with neutrophil hyper-reactivity 173
Oligomeric formylpeptide activity on human neutrophils 172
Detection methods for the identification of Alicyclobacillus species involved in food spoilage 172
Myelin basic protein inhibits formyl-peptide induced chemotaxis in human neutrophils 171
N-ureido peptide derivatives as antagonists towar human neutrophil formylpeptide receptor 171
Probing structural requirements of fMLP receptor: On the size of the hydrophobic pocket corresponding to residue 2 of the tripeptide 171
Structure activity relationship of for-Met-Leu-Phe-OMe analogues in human neutrophils 170
2-phenyl-2,3-dihydro-1H-imidazo[1,2-b]pyrozole derivatives: new potent inhibitors of fMLP-induced neutrophil chemotaxis 170
Biscarbamate analogues of the chemotactic tripeptide fMLF-OMe 168
FUNCTIONALITY AND DRUG METABOLISM OF FRESHLY AND CRYOPRESERVED CULTURED HUMAN HEPATOCYTES 168
Study of synthetic peptides derived from PKI55, a PKC modulator, in stimulated human neutrophils. 168
activation of signal transduction pathway leading to chemotaxis human neutrophils by a pure chemoattractant 167
Studies on human neutrophil biological functions by means of formylpeptide receptor agonists and antagonists 166
The Purinergic P2Z Receptor of Human Macrophage Cells: Characterization and Possible Physiological Role 164
N-Benzyl-2-chloroindole-3-carboxylic acids as potential anti-inflammatory agents. Synthesis and screening for the effects on human neutrophil functions and on COX1/COX2 activity 163
Chemotactic peptides: fMLF-OMe analogues incorporating proline-methionine chimeras as N-terminal residue 161
2-phenyl-1-arylcarbamoyl-2,3-dihydro-1H-imidazo[1,2-b]pyrazoles 7-substituted as potential neutrophil chemotaxis inhibitors 160
IL-8 enhances antibody-dependent cellular cytotoxicity in human neutrophils 158
Novel chemotactic For-Met-Leu-Phe-OMe (fMLF-OMe) analogues based on Met residue replacement by 4-amino-proline scaffold: Synthesis and bioactivity 158
chemotactic formylpeptides activation of protein kinase C and mitogen-activated protein kinases in human neutrophils 158
Evidence for the presence of N-formyl-methionyl-leucyl-phenylalanine (fMLP) receptor ligands in human amniotic fluid and fMLP receptor modulation by physiological labour 157
Synthesis and properties of chemotactic peptide analogs: II. HCO‐Met‐Leu‐Phe‐OMe analogs containing cyclic α,α‐disubstituted amino acids as Met and Phe mimicking residues 157
Synthesis, conformation, and biological activity of two fMLP-OMe analogues containing the new 2-[2'(methylthio) ethyl] methionine residue 157
alfa-Peptide/beta-sulfonamidopeptide hybrids: analogues of the chemotactic agent For-Met-Leu-Phe-OMe; 156
Isopeptide bonds in chemotactic tripeptides. Synthesis and activity of lysine-containing fMLF analogs 155
Synthesis and evaluation of diverse analogs of amygdalin as potential peptidomimetics of peptide T 155
A 'pure' chemoattractant formylpeptide analogue triggers a specific signalling pathway in human neutrophil chemotaxis 151
Protein kinase C mediates human neutrophil cytotoxicity 148
Synthesis and bioactivity of chemotactic tetrapeptides: FMLF-OMe analogues incorporating spacer aminoacids at the lateral positions 148
Peptide T-AraC Conjugates. Solid Phase Synthesis and Biological Activity of N4-(acylpeptidyl)-AraC 144
Pseudopeptides containing the 2-hydrazonoacyl fragment: Analogs of the chemotactic agent HCO-Met-Leu-Phe-OMe 143
Polymorphonuclear neutrophils pulsed with synthetic peptides efficiently activate memory cytotoxic T lymphocytes 143
CD16 and CR3 receptors distinguish between the two mechanisms of tumour cytotoxicity in neutrophils 142
Conformation-activity relationship of peptide t and new pseudocyclic hexapeptide analogs 142
The importance of the methionine configuration in for-Met-Leu-Phe-OMe biological activities. 140
Antibody-independent cytoxicity against human erythroleukemic K 562 human cells by neutrophils 139
Valutazione funzionale dei leucociti. 134
Interferon-gamma enhances monoclonal antibody 17-1A-dependent neutrophil cytotoxicity toward colorectal carcinoma cell line SW11-16 133
Expression and functional role of urokinase-type plasminogen activator receptor in normal and acute leukaemic cells 133
Exploring the interest of 1,2-Dithiolane ring system in peptide chemistry. Synthesis of a chemotactic tripeptide and x-ray crystal structure of a 4-amino-1,2-dithiolane-4-carboxylic acid derivative 131
FLOW CYTOMETRY STUDY OF CR1, CR3 AND GRANULE CONSTITUENTS IN NEUTROPHILS OF MDS PATIENTS AND HEALTHY CONTROLS: RELATIONSHIP WITH FUNCTIONAL ACTIVITIES AND DISEASE STATES 130
Effects of Synthetic Peptides on the Inflammatory Response and Their Therapeutic Potential. 128
Solution structure of the amino acid sequence coded by the rarely expressed exon 26A of human elastin: The N-terminal region 126
NEW CHEMOTACTIC PEPTIDE ANALOGS WITH HIGH BIOLOGICAL ACTIVITY FOR HUMAN NEUTROPHILS 121
NEUTROPHILS FROM PATIENTS WITH MYELODISPLASTIC SYNDROMES: RELATIONSHIP BETWEEN IMPAIRMENT OF GRANULAR CONTENTS, COMPLEMENT RECEPTORS, FUNCTIONAL ACTIVITIES AND DISEASE STATUS 121
Specific activation of mitogen-activated protein kinases and protein kinase C isoforms in formylpeptides-induced human neutrophils chemotaxis. 121
Two for-Met-Leu-Phe-OMe analogues trigger selective neutrophil responses. A differential effect on cytosolic free Ca2+ 120
Met-Ile-Phe-Leu derivates: full and partial agonist towards formyl peptide receptors of human neutrophils. 119
Identification of CD8+ T cell epitopes within lytic antigens of human herpes virus 8 118
Chemotactic effects of nociceptin/orphanin FQ on human monocytes are mediated by nop receptor activation 117
Peptide T revisited: Conformational mimicry of epitopes of anti-HIV proteins 114
Synthesis and activity of HCO-Met-Leu-Phe-OMe analogues containing ß-alanine or taurine at the central position 113
New-pyrazolyl-ureas as potent human neutrophil chemotaxis inhibitors 112
Effects of PKI55 protein, an endogenous protein kinase C modulator, on specific PKC isoforms activity and on human T cells proliferation 111
Synthetic formyl tripeptide chemoattractants: a C-alpha,C-alpha-dialkylated, amphiphilic glycyl residue at position 1 110
Synthesis and biological evaluation of new active For-Met-Leu-Phe-OMe analogues containing para-substituted Phe residues. J.Pept.Sci, 18, 418-426, 2012. 109
Totale 17.694
Categoria #
all - tutte 87.286
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.230
Totale 88.516


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.290 40 162 102 89 61 35 54 64 37 83 144 419
2022/20231.270 132 61 52 153 224 199 62 112 170 7 53 45
2023/2024517 69 66 31 14 27 106 23 51 9 3 4 114
2024/20252.531 67 30 183 72 349 253 138 154 407 274 343 261
2025/20267.512 763 553 704 1.062 1.069 498 730 357 655 808 248 65
2026/2027188 188 0 0 0 0 0 0 0 0 0 0 0
Totale 20.306